The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Informa lifts FTSE 100; pound above USD1.18

Mon, 14th Nov 2022 08:58

(Alliance News) - Stocks in London were mostly lower on Monday, though the FTSE 100 was in the green as investors looked ahead to the UK budget statement later in the week, which Chancellor Jeremy Hunt promised to be "rabbit-free".

The FTSE 100 index opened up 50.14 points, 0.7%, at 7,368.18.

However, the mid-cap FTSE 250 was down 33.86 points, or 0.2%, at 19,582.35, and the AIM All-Share was down 1.80 points, 0.2%, at 853.04.

The Cboe UK 100 was up 0.5% at 736.31. The Cboe UK 250 down 0.3% at 16,884.29. The Cboe Small Companies was up 0.4% at 12.957.88.

UK government ministers said they are determined to crack down on an "outrageous" waste of public money, while seeking billions in tax hikes and savings, as the chancellor warned he will be playing Scrooge at the upcoming autumn budget.

Hunt has promised a "rabbit-free" statement, with a focus on delivering "certainty" to families and businesses in the wake of the market turmoil sparked by his predecessor's GBP45 billion tax-cutting bonanza.

He is thought to be considering a range of options to address a so-called black hole in the public finances, including an extended freeze on income tax and national insurance thresholds.

The autumn statement will be announced on Thursday.

Analysts at ING said: "The UK chancellor, Jeremy Hunt, has been ramping up the rhetoric that Thursday's autumn statement is going to hurt - comprising tax rises for all and a large cut in government spending. None of the choices are politically palatable, but failure to deliver would trigger another round of Gilt and sterling sales."

The pound rose to USD1.1803 on Monday morning in London, from USD1.1781 late Friday. Against the yen, the dollar was quoted at JPY139.53, up from JPY139.07.

The euro traded at USD1.0333, up slightly from USD1.0326. A week ago, the single currency was still trading below parity with the dollar.

"The severity of the EURUSD correction has caught out many (including ourselves)...Even the European Central Bank's Luis De Guindos said on Friday that he felt markets had overreacted to the US CPI data. The very difficult question is whether this short EURUSD squeeze has run its course near 1.0365 or needs to trade higher still," ING analysts added.

US inflation cooled by more than expected in October. The consumer price index rose 7.7% last month against the prior year, according to figures released on Thursday last week, slowing from the 8.2% rise recorded in September. Market consensus had expected inflation to slow by less than that, to 8.0% in October.

Stocks on the continent were higher. The CAC 40 index in Paris was up 0.4%, while the DAX 40 in Frankfurt was 0.5% higher.

In Asia, stocks were in the mixed. The Shanghai Composite in China closed 0.1% lower, while the Hang Seng in Hong Kong closed up 1.7%. In Tokyo, the Nikkei 225 closed down 1.1%, while the S&P/ASX 200 in Sydney closed down 0.2%.

US President Joe Biden on Sunday said he will seek to establish "red lines" in America's fraught relations with Beijing when he holds high-stakes talks with Chinese counterpart Xi Jinping.

Biden said he goes into Monday's encounter on the sidelines of a G20 summit in Indonesia stronger after his Democratic Party's unexpected success in midterm elections they were forecast to lose heavily.

Washington and Beijing are at loggerheads over issues ranging from trade to human rights in China's Xinjiang region and the status of the self-ruled island of Taiwan. Biden said he expected candid talks with Xi.

"Any signs of a further deterioration in the relationship is likely to rattle markets and investors will be clinging onto hopes that there could be communication re-boot," said Susannah Streeter, analyst at Hargreaves Lansdown.

In London, Informa led the FTSE 100, rising 6.4% in early morning trade as it upgraded its full-year outlook on the back of strong underlying revenue growth in the first 10 months of the year.

The business publisher and events organiser reported underlying revenue growth of 41% in its continuing business in the 10-months to October, thanks to strong trading in all three of its Business-to-Business Markets businesses and in its Academic Market business.

Informa said 2022 performance is tracking toward 85% of equivalent full-year revenue in 2019, when excluding China, which has been hurt by Covid-19 restrictions.

AstraZeneca was up 1.6% as it gained recommendation for marketing authorisation in the EU for three of its cancer treatments, Enhertu, Imfinzi and Lynparza.

Enhertu won recommended approval in the treatment of gastric cancer in those who have received a prior regimen of trastuzumab, another cancer drug. Imfinzi gained recommendation for approval in biliary tract cancer when in combination with chemotherapy, and Lynparza for prostate cancer.

Aveva was up 0.3%. The industrial software firm said that the Schneider Electric has the support of 4.1% of its shareholders, representing 10% of all shares not already held by Schneider.

On Friday, the two companies announced they had agreed an increase and final cash offer for Schneider's takeover of Aveva, of which it already owns a 59% stake.

Schneider offered 3,225 pence in cash for each Aveva share, which valued Aviva equity at GBP9.86 billion, and implied an enterprise value of GBP10.57 billion. The offer was around 4% higher than that agreed a couple of months ago.

In the FTSE 250, Ferrexpo was down 6.6% after Credit Suisse cut the Ukraine iron ore exporter to 'neutral' from 'outperform'.

Kainos was up 1.9% as Chief Executive Brendan Mooney boasted that demand for the firm's services has "never been higher" amid a rise in interim profit and revenue.

In the six months ended September 30, Kainos posted revenue totalling GBP179.8 million, up 26% against the GBP142.3 million achieved the year prior. Pretax profit rose 11% to GBP27.5 million from GBP24.8 million.

In the small-caps, ME Group jumped 3.6%. The instant-service equipment firm said that its first half performance was ahead of its expectations, noting higher consumer demand for all its services and a strong recovery across continental Europe.

As a result, ME Group lifted its full-year outlook once again. Revenue is now expected between GBP256 million and GBP262 million. Previously, the company expected revenue at GBP257 million.

Gold fell to USD1,761.45 an ounce early Monday from USD1,763.60 late Friday. Brent oil fetched USD95.95 a barrel, down slightly from USD96.32.

Still to come on Monday, there is an EU industrial production print at 1000 GMT.

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.